Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.

Nguyen QN, Ly NB, Komaki R, Levy LB, Gomez DR, Chang JY, Allen PK, Mehran RJ, Lu C, Gillin M, Liao Z, Cox JD.

Radiother Oncol. 2015 Jun;115(3):367-72. doi: 10.1016/j.radonc.2015.05.014. Epub 2015 May 28.

2.

Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.

Gomez DR, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, Pan HY, Chang JY, Komaki R, Cox JD, McAleer MF, Grosshans DR.

J Thorac Oncol. 2014 Oct;9(10):1554-60. doi: 10.1097/JTO.0000000000000306.

3.

Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.

Kardar L, Li Y, Li X, Li H, Cao W, Chang JY, Liao L, Zhu RX, Sahoo N, Gillin M, Liao Z, Komaki R, Cox JD, Lim G, Zhang X.

Pract Radiat Oncol. 2014 Nov-Dec;4(6):e259-68. doi: 10.1016/j.prro.2014.06.010. Epub 2014 Aug 12.

4.

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial.

Zhu Z, Liu W, Gillin M, Gomez DR, Komaki R, Cox JD, Mohan R, Chang JY.

Radiat Oncol. 2014 May 6;9:108. doi: 10.1186/1748-717X-9-108.

5.

Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.

Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):846-53. doi: 10.1016/j.ijrobp.2014.04.019. Epub 2014 May 24.

6.

On the interplay effects with proton scanning beams in stage III lung cancer.

Li Y, Kardar L, Li X, Li H, Cao W, Chang JY, Liao L, Zhu RX, Sahoo N, Gillin M, Liao Z, Komaki R, Cox JD, Lim G, Zhang X.

Med Phys. 2014 Feb;41(2):021721. doi: 10.1118/1.4862076.

7.

Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.

Welsh J, Amini A, Ciura K, Nguyen N, Palmer M, Soh H, Allen PK, Paolini M, Liao Z, Bluett J, Mohan R, Gomez D, Cox JD, Komaki R, Chang JY.

Med Dosim. 2013 Winter;38(4):442-7. doi: 10.1016/j.meddos.2013.08.001.

8.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):885-91. doi: 10.1016/j.ijrobp.2013.04.006.

9.

TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.

Yuan X, Wei Q, Komaki R, Liu Z, Yang J, Tucker SL, Xu T, Heymach JV, Lu C, Cox JD, Liao Z.

PLoS One. 2013 Jun 19;8(6):e65659. doi: 10.1371/journal.pone.0065659. Print 2013.

10.

Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.

Gomez DR, Gillin M, Liao Z, Wei C, Lin SH, Swanick C, Alvarado T, Komaki R, Cox JD, Chang JY.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):665-70. doi: 10.1016/j.ijrobp.2013.03.035. Epub 2013 May 18.

11.

Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.

Wang J, Myles B, Wei C, Chang JY, Hofstetter WL, Ajani JA, Swisher SG, Cox JD, Komaki R, Liao Z, Lin SH.

Dis Esophagus. 2014 Feb-Mar;27(2):168-75. doi: 10.1111/dote.12074. Epub 2013 Apr 26.

12.

Aortic dose constraints when reirradiating thoracic tumors.

Evans JD, Gomez DR, Amini A, Rebueno N, Allen PK, Martel MK, Rineer JM, Ang KK, McAvoy S, Cox JD, Komaki R, Welsh JW.

Radiother Oncol. 2013 Mar;106(3):327-32. doi: 10.1016/j.radonc.2013.02.002. Epub 2013 Feb 28.

13.

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC.

Ann Oncol. 2013 Jan;24(1):67-74. doi: 10.1093/annonc/mds274. Epub 2012 Sep 20.

14.
15.

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.

Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, Liu H, Komaki R, Cox JD, Liao Z.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):1010-6. doi: 10.1016/j.ijrobp.2012.01.071. Epub 2012 Aug 21.

16.

Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.

Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1078-85. doi: 10.1016/j.ijrobp.2012.02.015. Epub 2012 Aug 3.

17.

Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.

Lopez Guerra JL, Gomez D, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1573-9. doi: 10.1016/j.ijrobp.2011.10.065.

18.

Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.

Tucker SL, Michalski JM, Bosch WR, Mohan R, Dong L, Winter K, Purdy JA, Cox JD.

Radiother Oncol. 2012 Jul;104(1):109-13. doi: 10.1016/j.radonc.2012.04.023. Epub 2012 Jun 5.

19.

Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, Parliament M, Purdy JA, Valicenti RK, Cox JD.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e363-70. doi: 10.1016/j.ijrobp.2011.12.070.

20.

Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.

Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1093-100. doi: 10.1016/j.ijrobp.2012.02.041. Epub 2012 Apr 27.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk